Clinical trial
An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
NCT00776659 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study Of Indian Breast Cancer Patients Receiving Adjuvant Therapy With Aromasin
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 31, 2008
- Completion date
- September 30, 2012
- Enrollment
- 39 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.